Objective

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. 

The objective of this initiative is to create a highly competitive opportunity for promising regenerative medicine (stem cell-based or gene therapy) projects that accelerate completion of translational stage activities necessary for advancement to clinical study or broad end use for any one of the following product types:

• TRAN 1: Stem cell-based or gene therapy therapeutic candidate 
• TRAN 2: Diagnostic (including medical imaging agents) based on stem cells, or critical for stem cell-based or gene therapy development or use 
• TRAN 3: Medical device (non-diagnostic) for a stem cell-based therapy or critical for stem cell-based or gene therapy development or use 
• TRAN 4: Novel tool that addresses a critical bottleneck to the discovery or development of stem cell-based or gene therapy 

Please see our Funding Opportunities page for more details